国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

億騰醫藥  Eddingpharm
億騰成立于2001年，作為中國領(lǐng)先的專(zhuān)業(yè)醫藥公司，我們長(cháng)期以來(lái)一直致力于將全球優(yōu)質(zhì)的藥品帶入中國醫療市場(chǎng)，提供給病患更多的治療及康復機會(huì )，促進(jìn)中國臨床專(zhuān)家和全球領(lǐng)先醫學(xué)研究機構的合作和交流，為中國臨床醫生提供學(xué)術(shù)支持。

公司自2001年成立以來(lái)，發(fā)展至2011年底，在國內雇員已超過(guò)700名，主要從事藥品的經(jīng)銷(xiāo)和推廣、產(chǎn)品注冊以及臨床試驗的管理等業(yè)務(wù)。

公司于2012年3月在美國成立Eddingpharm (U.S.) Company,并在洛杉磯組建了具備研發(fā)背景的產(chǎn)品發(fā)展團隊，主要從事與全球領(lǐng)先的研發(fā)機構的協(xié)調和溝通，尋求將處于臨床前或臨床試驗階段的創(chuàng )新專(zhuān)利藥物引進(jìn)中國市場(chǎng)的機會(huì )。

公司聚焦于臨床營(yíng)養、抗腫瘤治療、抗感染治療、呼吸系統疾病治療等領(lǐng)域的產(chǎn)品發(fā)展以及醫學(xué)推廣。

我們力爭通過(guò)和跨國醫藥公司、海外專(zhuān)業(yè)醫藥公司、全球領(lǐng)先研發(fā)機構等合作，以專(zhuān)利授權引進(jìn)、成立合資公司、建立戰略聯(lián)盟、獨家經(jīng)銷(xiāo)等形式建立聚焦于上述四個(gè)主要治療領(lǐng)域的產(chǎn)品組合。

目前億騰已與多家跨國醫藥公司和海外專(zhuān)業(yè)醫藥公司建立起長(cháng)期合作的關(guān)系，在上述四個(gè)治療領(lǐng)域建立了富有市場(chǎng)競爭優(yōu)勢的產(chǎn)品組合以及產(chǎn)品線(xiàn)；同時(shí)億騰還在積極發(fā)展與全球領(lǐng)先研發(fā)機構合作,授權引進(jìn)創(chuàng )新藥物的中國市場(chǎng)權利。

經(jīng)過(guò)多年的努力，至2011年年底億騰的市場(chǎng)學(xué)術(shù)推廣人員發(fā)展超過(guò)600名，針對中國市場(chǎng)已形成一套高度整合與管理良好的市場(chǎng)營(yíng)銷(xiāo)系統，醫學(xué)推廣覆蓋至全國大部分主要城市，同年12月底我們經(jīng)銷(xiāo)的產(chǎn)品或醫學(xué)推廣代表覆蓋至超過(guò)2900家醫院。

Eddingpharm was founded in 2001. As China’s leading pharmaceuticals marketing company, Eddingpharm has been committed to bring in high quality medicines from all over  the world to the Chinese market, to provide patients more treatment options and better opportunity of recovery.  We promote the cooperation and exchanges between Chinese clinical experts and the leading international medical research institutions. We provide academic support to Chinese clinical doctors.

Since its inception in 2001, the company has grown into an organization of more than 700 employees in China by the end of  2012. The company focuses on product sales and marketing, product registration,  and clinical trials management.

In March, 2012, Eddingpharm established Eddingpharm (U.S.) Company in USA, and set up a business development team with strong research and development background. The team is engaged in coordination and communication with the world’s leading research and development institutions and biotech companies. It is actively seeking the opportunity to introduce innovative proprietary medicines in pre-clinical or clinical development phase into the Chinese market.

The company is engaged in the product development and sales and marketing in four core therapeutic areas: clinical nutrition, oncology, antibiotics and respiratory-system.
 

We strive to create a portfolio of products focused on the above mentioned four major therapeutic areas, through strategic alliance, including exclusive distribution, product in-licensing, and joint-venture, with world’s leading pharmaceutical companies, overseas specialized pharmaceutical companies, and global leading research and development focused biotech companies.
 

Eddingpharm has established long-term cooperative relationship with a number of multinational pharmaceutical companies and overseas specialty pharmaceutical companies, and has built up a competitive product portfolio and pipeline in the four major therapeutic areas. At the same time, Eddingpharm is actively developing cooperation with the leading global biotech companies and research and development institutions to gain the regional rights of innovative medicines and to introduce them to the China market.
 

Through years effort, Eddingpharm has assembled  a team of nearlysales and marketing professionals and established a highly integrated and well-managed sales network covering most of the major cities across the country. By December 2012, our products and our sales and marketing professionals have covered more than 3000 hospitals.